Context Therapeutics Inc Share Price

NASDAQ: CNTX

Small Cap

$0.83

(+-0.51%)

as on September 13, 2025 at 1:15 am IST

$₹

Context Therapeutics Inc Stock Performance

as on September 13, 2025 at 1:15 am IST

Day's Low
Day's High
$0.81
Day's Price Range
$0.86
$0.83
2.41%
Downside
3.61%
Upside
52 Week's Low
52 Week's High
$0.49
52-Week Price Range
$2.59
$0.83
40.96%
Downside
212.04%
Upside

Context Therapeutics Inc share price movements today

Previous Close: $0.84
Open: $0.85
Volume: 276.8K
Day's Low - High: $0.81 - $0.86
52 Week Low - High: $0.49 - $2.59

Context Therapeutics Inc Historical Returns

1 Month Return: + 6.19 %
3 Month Return: + 32.67 %
1 Year Return: -60.05 %
3 Year Return: -48.46 %
5 Year Return: 0 %

Context Therapeutics Inc Stock Fundamentals & Key Indicators

Check Context Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$74.9M

EPS (TTM)

-0.3117

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-38.3M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

9196800.00%

Context Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Context Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Context Therapeutics Inc	BUY	$74.9M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Context Therapeutics Inc Stock including INR - Dollar returns

The Context Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Context Therapeutics Inc investment value today

Current value as on today

₹44,852

Returns

₹55,148

(-55.15%)

Returns from Context Therapeutics Inc Stock

₹60,287 (-60.29%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Context Therapeutics Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Context Therapeutics Inc. Average target price of $5.2

Context Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Context Therapeutics Inc.

What analysts predicted

84.04%UPSIDE

Target Price

$5.2

Current Price

$0.83

Analyzed by

8 Analysts

Target

$5.20

Context Therapeutics Inc target price $5.2, a slight upside of 84.04% compared to current price of $0.83. According to 8 analysts rating.

Context Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Context Therapeutics Inc Stock has increased by 59% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 16, 2025 to September 15, 2025

Change:59% versus previous 30 day period

Context Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	-	-	-	0
Operating Income	-6	-5	-6	-6	-3	-3	-18	-4	-5	-9
EBITDA	-6	-5	-6	-6	-3	-3	-18	-4	-5	-8
Interest Expense	0	-	-	0	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-6	-5	-5	-6	-3	-2	-17	-3	-4	-8
Income Tax Expense	0	0	0	0	0	0	-	-	-	-
Net Income	-6	-5	-5	-6	-3	-2	-17	-3	-4	-8
Net Profit Margin	0.00%	0.00%	0.00%	-35721.82%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Context Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	0	0	-
Operating Income	-33	-24	-5	-2	-10	-15	-25	-29
EBITDA	-	-	-5	-2	-10	-14	-25	-26
Interest Expense	-	-	1	0	0	0	-	-
Depreciation	-	-	-	-	-	0	0	0
Income Before Tax	-37	-25	-6	6	-10	-14	-23	-26
Income Tax Expense	-	0	1	0	-3	0	0	-
Net Income	-37	-24	-7	6	-10	-14	-23	-26
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Context Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-5	-5	-6	-3	-2	-17	-3	-4	-8
Operating Cash Flow	-4	-3	-7	-4	-3	-1	-4	-5	5
Investing Cash Flow	-	-	-	-	-	-14	-	0	-
Financing Cash Flow	-	-	-	-	94	0	14	0	-
Change in Cash	-4	-3	-7	-4	91	-16	9	-5	-5

Context Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-24	-6	6	-10	-14	-23	-26
Operating Cash Flow	-22	-2	-1	-8	-13	-21	-14
Investing Cash Flow	0	0	0	0	0	-	-14
Financing Cash Flow	66	1	1	58	0	-	109
Change in Cash	44	0	0	49	-14	-21	79

Global Institutional Holdings in Context Therapeutics Inc

Funds	Holdings
MPM Oncology Impact Management LP	16.39%
Avidity Partners Management LP	8.34%
Deep Track Capital, LP	8.27%
Nextech Invest, Ltd.	8.27%
Blue Owl Capital Holdings LP	8.21%

See all

Insights on Context Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 172.0%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 135.6%
NEGATIVE IMPACT
Price Dip
In the last 1 year, CNTX stock has moved down by -60.0%

About Context Therapeutics Inc

context therapeutics is dedicated to discovering, acquiring, and developing novel compounds to treat hormone responsive cancers. our lead program is apristor (onapristone xr), an investigational drug for progesterone receptor positive (pr+) breast cancer. up to 70% of breast cancers express progesterone receptor (pr). if your cancer is pr+, apristor could be an option for you.

Organisation	Context Therapeutics Inc
Headquarters	2001 Market Street, Philadelphia, PA, United States, 19103
CEO	Mr. Martin A. Lehr
E-voting on shares	Click here to vote

Key Management of Context Therapeutics Inc

Name	Title
Dr. Karen Chagin M.D.	Chief Medical Officer
Mr. Martin A. Lehr	Co-Founder, President, CEO & Director
Ms. Jennifer Minai-Azary	CFO & Treasurer
Mr. Alex C. Levit Esq., J.D.	Chief Legal Officer & Corporate Secretary
Mr. Christopher Beck M.B.A.	Senior Vice President of Operations
Mr. Jeffrey Liebman	Associate Director of Accounting
Ms. Jennifer Dashnau M.B.A., Ph.D.	Senior Vice President of Technical Operations

FAQs

What is Context Therapeutics Inc share price today?

Context Therapeutics Inc share price today is $0.83 as on September 13, 2025 at 1:15 am IST at the close of the market. Context Therapeutics Inc share today touched a day high of $0.86 and a low of $0.81.

What is the 52 week high and 52 week low for Context Therapeutics Inc share?

Context Therapeutics Inc share touched a 52 week high of $2.59 on October 23, 2024 and a 52 week low of $0.49 on May 30, 2025. Context Therapeutics Inc stock price today i.e. September 13, 2025 at 1:15 am IST is closed at $0.83,which is 67.95% down from its 52 week high and 69.39% up from its 52 week low.

What is Context Therapeutics Inc's market capitalisation today?

Context Therapeutics Inc market capitalisation is $0.00T as on September 13, 2025 at 1:15 am IST.

How to invest in Context Therapeutics Inc Stock (CNTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Context Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Context Therapeutics Inc Shares that will get you 1.8072 shares as per Context Therapeutics Inc share price of $0.83 per share as on September 13, 2025 at 1:15 am IST.

What is the minimum amount required to buy Context Therapeutics Inc Stock (CNTX) from India?

Indian investors can start investing in Context Therapeutics Inc (CNTX) shares with as little as ₹88.27 or $1 (as of September 15, 2025 at 2:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Context Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 15, 2025 at 2:40 pm IST). Based on Context Therapeutics Inc share’s latest price of $0.83 as on September 13, 2025 at 1:15 am IST, you will get 12.0482 shares of Context Therapeutics Inc. Learn more about fractional shares .